Compounds > 2,2',3,3',4,4'-hexahydroxy-1,1'-biphenyl-6,6'-dimethanol dimethyl ether

2,2',3,3',4,4'-hexahydroxy-1,1'-biphenyl-6,6'-dimethanol dimethyl ether and diphenyleneiodonium

2,2',3,3',4,4'-hexahydroxy-1,1'-biphenyl-6,6'-dimethanol dimethyl ether has been researched along with diphenyleneiodonium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Devaraj, S; Jialal, I; Venugopal, SK; Yang, T	1

Other Studies

1 other study(ies) available for 2,2',3,3',4,4'-hexahydroxy-1,1'-biphenyl-6,6'-dimethanol dimethyl ether and diphenyleneiodonium

Article	Year
Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes, 2002, Volume: 51, Issue:10 Topics: Acetophenones; alpha-Tocopherol; Antioxidants; Biphenyl Compounds; Cell Line; Ellagic Acid; Enzyme Activation; Enzyme Inhibitors; Humans; Hyperglycemia; Isoenzymes; Mesylates; Monocytes; NADPH Oxidases; Oligodeoxyribonucleotides, Antisense; Onium Compounds; Phosphoproteins; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pyrroles; Superoxides	2002

Article

Year

Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha.

Diabetes, 2002, Volume: 51, Issue:10

Topics: Acetophenones; alpha-Tocopherol; Antioxidants; Biphenyl Compounds; Cell Line; Ellagic Acid; Enzyme Activation; Enzyme Inhibitors; Humans; Hyperglycemia; Isoenzymes; Mesylates; Monocytes; NADPH Oxidases; Oligodeoxyribonucleotides, Antisense; Onium Compounds; Phosphoproteins; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pyrroles; Superoxides

2002